Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05156112 · ClinicalTrials.gov registry record · NA

OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit

A NA study of Obstructive Sleep Apnea and Post Traumatic Stress Disorder, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
194
Enrollment target
1
Study location

NCT05156112 is a NA study of Obstructive Sleep Apnea and Post Traumatic Stress Disorder that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 194 participants, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05156112, a NA study of Obstructive Sleep Apnea and Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
194 participants
Enrollment target
1
Study location

Study Summary

Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more severe than outpatient settings. Obstructive sleep apnea (OSA) is highly comorbid with both disorders and untreated OSA is associated with worse functional impairment across multiple domains, worse quality of life, worse PTSD, higher suicidal ideation, and higher substance use and relapse rates. Treating OSA with evidence-based positive airway pressure (PAP) in Veterans with SUD/PTSD on a residential unit is a logical way to maximize treatment adherence and treatment outcomes. This study compares OSA treatment while on a SUD/PTSD residential unit to a waitlist control group. The investigators hypothesize that treating OSA on the residential unit, compared to the waitlist control, will have better functional, SUD, and PTSD outcomes.

Interventions

  • DEVICE Positive Airway Pressure Device

Study Locations (1)

California

  • VA San Diego Healthcare System, San Diego, CA - San Diego

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2023-01-02
Est. Completion 2027-05-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05156112

The ClinicalTrials.gov registry entry for NCT05156112 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 220-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (12% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Positive Airway Pressure Device is the first listed.

NCT05156112 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05156112 about?

NCT05156112 is a clinical study titled "OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit". Substance use disorder (SUD) and posttraumatic stress disorder (PTSD) frequently co-occur and having both disorders is associated with greater psychological and functional impairment than having either disorder alone. This is especially true in residential settings where both disorders are more seve...

What is the current status of trial NCT05156112?

This trial is currently recruiting. It is a NA study. The enrollment target is 194 participants. The study started on 2023-01-02. Estimated completion is 2027-05-31.

What conditions does trial NCT05156112 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Post Traumatic Stress Disorder, Substance Use Disorder, Residential Treatment Program.

What interventions are being tested in trial NCT05156112?

The interventions under investigation include: Positive Airway Pressure Device (DEVICE).

Who is sponsoring clinical trial NCT05156112?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05156112 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.